In the last week, the Pharma industry is up 3.5%, with Lotus Pharmaceutical leading the way, up 5.9%. During this same period, the Oneness Biotech underperformed, falling 11%. This takes the industry's 12 month performance to a gain of 7.0%. As for the next few years, earnings are expected to grow by 59% per annum.
Has the Taiwanese Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE |
---|---|---|---|---|
Fri, 01 Jul 2022 | NT$409.1b | NT$76.8b | NT$4.4b | 21.6x |
Sun, 29 May 2022 | NT$378.3b | NT$76.8b | NT$4.4b | 20.5x |
Tue, 26 Apr 2022 | NT$392.7b | NT$76.5b | NT$6.5b | 21.6x |
Thu, 24 Mar 2022 | NT$398.8b | NT$76.6b | NT$8.9b | 20.7x |
Sat, 19 Feb 2022 | NT$404.2b | NT$76.7b | NT$8.5b | 19.3x |
Mon, 17 Jan 2022 | NT$370.8b | NT$76.7b | NT$8.5b | 18.8x |
Wed, 15 Dec 2021 | NT$390.8b | NT$76.7b | NT$8.5b | 18.4x |
Fri, 12 Nov 2021 | NT$362.1b | NT$75.7b | NT$10.1b | 17.3x |
Sun, 10 Oct 2021 | NT$348.0b | NT$76.0b | NT$10.7b | 18.9x |
Tue, 07 Sep 2021 | NT$358.0b | NT$76.0b | NT$10.7b | 19.7x |
Thu, 05 Aug 2021 | NT$367.5b | NT$76.0b | NT$10.7b | 21.4x |
Sun, 09 May 2021 | NT$358.3b | NT$74.2b | NT$12.5b | 18.7x |
Wed, 10 Feb 2021 | NT$300.3b | NT$72.4b | NT$8.6b | 17.1x |
Tue, 03 Nov 2020 | NT$356.2b | NT$71.7b | NT$6.3b | 18.5x |
Fri, 07 Aug 2020 | NT$328.7b | NT$70.9b | NT$5.6b | 20.6x |
Thu, 30 Apr 2020 | NT$231.6b | NT$70.2b | NT$1.8b | 22.3x |
Sun, 02 Feb 2020 | NT$224.7b | NT$69.7b | NT$1.3b | 21.6x |
Wed, 06 Nov 2019 | NT$231.9b | NT$69.1b | NT$5.9b | 21.2x |
Sat, 10 Aug 2019 | NT$228.5b | NT$73.2b | NT$7.4b | 21.6x |
19.8x
How does Taiwanese Pharma compare with similar industries?
TW Market | -2.33% | |
Healthcare | 0.34% | |
Pharma | 0.44% | |
Pharma | 0.44% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
1795 Lotus Pharmaceutical | NT$153.50 | 5.9% +NT$2.2b | 49.8% | PE28.7x | |
6472 Bora Pharmaceuticals | NT$266.00 | 12.2% +NT$2.0b | 20.6% | PE30.5x | |
6586 CHO Pharma | NT$170.50 | 4.6% +NT$1.4b | 354.7% | PS8788.7x | |
1760 Panion & Bf Biotech | NT$120.00 | 13.2% +NT$1.2b | 22.0% | PE61x | |
4123 Center Laboratories | NT$60.20 | 2.9% +NT$858.6m | -3.6% | PE28.8x |